AI assistant
Sending…
EBOS GROUP LIMITED — Director's Dealing 2022
Sep 5, 2022
64813_rns_2022-09-05_01ebbdd4-9ebb-4264-b8ab-3aa7786a0b6b.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [98 x 35] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 6-Sep-22 | |
| Date of last disclosure: | 31-Jan-22 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | John Cullity | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Chief Executive Officer | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | ||
| Class ofaffected quotedfinancialproducts: | Ordinaryshares | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to performance | |
| rightsplan | ||
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 1,458 ordinaryshares | |
| Number held in class after acquisition or disposal: | 24,186 ordinaryshares | |
| Current registered holder(s): | N/A | |
| Registeredholder(s) once transfers areregistered: | John Cullity |
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 6-Sep-22 | |
| Date of last disclosure: | 31-Jan-22 | |
| Director or senior manager giving disclosure | ||
Full name(s): |
John Cullity | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Chief Executive Officer | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
||
| Class ofaffected quotedfinancialproducts: | Ordinaryshares | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to performance rightsplan |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 1,458 ordinaryshares | |
| Number held in class after acquisition or disposal: | 24,186 ordinaryshares | |
| Current registered holder(s): | N/A | |
| Registeredholder(s) once transfers areregistered: | John Cullity | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab | le) | |
| Type of affected derivative: | ||
| Class of underlyingfinancialproducts: | ||
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
||
| A statement as to whether the derivative is cash settled orphysicallysettled: | ||
| Maturitydate of the derivative(if any): | ||
| Expirydate of the derivative(if any): | ||
| Theprice specified in the terms of the derivative(if any): | ||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
||
| _For that derivative,- _ | ||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
||
| Details of transactions giving rise to acquisition or disposal | ||
| Total numberoftransactions towhich noticerelates: | 1 | |
| 1-Sep-22 | ||
| Issue of shares pursuant to performance rightsplan |
||
| N/A | ||
| Nil | ||
| 22,728 ordinaryshares | ||
| No |
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
N/A | N/A | |
|---|---|---|---|
| Date of theprior written clearance(if any): | N/A | ||
| Summary of other relevant interests after acquisition or disposal: | |||
| Class ofquotedfinancialproducts: | |||
| Nature of relevant interest: | |||
| _For that relevant interest,- _ | |||
| Number heldinclass: | |||
| Currentregisteredholder(s): | |||
| For a derivative relevant interest,- | |||
| Type ofderivative: | |||
| Details of derivative,- | |||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
|||
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturity date of the derivative (if any): | |||
| Expiry date of the derivative (if any): | |||
| The price's specified terms (if any): | |||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
|||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
|||
| Certification | 6-Sep-22 Janelle Cain, General Counsel, EBOS Group Limited |
||
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
|||
| Signature of director or officer: | |||
| Date of signature: | |||
| or | |||
| Signature of person authorised to sign on behalf of director or officer: | |||
| Date of signature: | |||
| Name and title of authorised person: | |||
==> picture [98 x 35] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 6-Sep-22 | |
| Date of last disclosure: | 31-Jan-22 | |
| Director or senior manager giving disclosure | ||
Full name(s): |
Brett Barons | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | CEO,Symbion | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- |
||
| Class ofaffected quotedfinancialproducts: | Ordinaryshares | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to performance rightsplan |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 1,458 ordinaryshares | |
| Number held in class after acquisition or disposal: | 11,686 ordinaryshares | |
| Current registered holder(s): | N/A | |
| Registered holder(s) once transfers are registered: | Brett Barons | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab | le) | |
| Type of affected derivative: | ||
| Class of underlyingfinancialproducts: | ||
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
||
| A statement as to whether the derivative is cash settled orphysicallysettled: | ||
| Maturitydate of the derivative(if any): | ||
| Expirydate of the derivative(if any): | ||
| Theprice specified in the terms of the derivative(if any): | ||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
||
| _For that derivative,- _ | ||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
||
| Details of transactions giving rise to acquisition or disposal | ||
| Total numberoftransactions towhich noticerelates: | 1 | |
| 1-Sep-22 | ||
| Issue of shares pursuant to performance rightsplan |
||
| N/A | ||
| Nil | ||
| 10,228 ordinaryshares | ||
| No |
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
N/A | N/A | |
|---|---|---|---|
| Date of theprior written clearance(if any): | N/A | ||
| Summary of other relevant interests after acquisition or disposal: | |||
| Class ofquotedfinancialproducts: | |||
| Nature of relevant interest: | |||
| _For that relevant interest,- _ | |||
| Number heldinclass: | |||
| Currentregisteredholder(s): | |||
| For a derivative relevant interest,- | |||
| Type ofderivative: | |||
| Details of derivative,- | |||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
|||
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturity date of the derivative (if any): | |||
| Expiry date of the derivative (if any): | |||
| The price's specified terms (if any): | |||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
|||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
|||
| Certification | 6-Sep-22 Janelle Cain, General Counsel, EBOS Group Limited |
||
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
|||
| Signature of director or officer: | |||
| Date of signature: | |||
| or | |||
| Signature of person authorised to sign on behalf of director or officer: | |||
| Date of signature: | |||
| Name and title of authorised person: | |||
==> picture [98 x 27] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 6-Sep-22 | |
| Date of last disclosure: | 15-Oct-20 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | LeonardHansen | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Chief FinancialOfficer | |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
| Class of affected quoted financial products: | Ordinary shares | |
|---|---|---|
| Nature of the affected relevant interest(s): | Issue of shares pursuant to performance rightsplan |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 327 | |
| Number held in class after acquisition or disposal: | 1,472 | |
| Current registered holder(s): | N/A | |
| Registered holder(s) once transfers are registered: | Leonard Hansen |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
| le) | ||
|---|---|---|
| N/A | ||
| N/A | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
N/A | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | |
| Maturitydate of the derivative(if any): | N/A | |
| Expirydate of the derivative(if any): | N/A | |
| Theprice specified in the terms of the derivative(if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: |
N/A | |
| For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
||
| Parties to the derivative: | N/A | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
N/A | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total numberoftransactions towhich noticerelates: | 1 | |
| 1-Sep-22 | ||
| Issue of shares pursuant to performance rightsplan |
||
| N/A |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration: |
Nil | Nil | |
|---|---|---|---|
| Numberof financialproducts towhichthe transaction related: | 1,145 ordinary shares | ||
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
|||
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | No | ||
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
N/A | ||
| Date of theprior written clearance(if any): | N/A | ||
| Summary of other relevant interests after acquisition or disposal: Class ofquotedfinancialproducts: Nature of relevantinterest: For that relevant interest,- Number heldinclass: Currentregisteredholder(s): For a derivative relevant interest,- Type ofderivative: Details of derivative,- |
|||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
N/A | ||
| A statement as to whether the derivative is cash settled or physically settled: | N/A | ||
| Maturity date of the derivative (if any): | N/A | ||
| Expiry date of the derivative (if any): | N/A | ||
| The price's specified terms (if any): | N/A | ||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
N/A | ||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | N/A | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
N/A |
Certification
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
||
|---|---|---|
| Signature of director or officer: | ||
| Date of signature: | ||
| or | ||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | 6-Sep-22 | |
| Name and title of authorised person: | Janelle Cain, General Counsel, EBOS Group Limited |
|
More from EBOS GROUP LIMITED
Share Issue/Capital Change
2026
May 18
Share Issue/Capital Change
2026
May 18
Share Issue/Capital Change
2026
May 17
Share Issue/Capital Change
2026
May 17
Share Issue/Capital Change
2026
May 17
Share Issue/Capital Change
2026
May 17
Capital/Financing Update
2026
May 6
Share Issue/Capital Change
2026
May 5
Capital/Financing Update
2026
May 5
Regulatory Filings
2026
May 1